Cargando…

Potential risk factors for diabetic neuropathy: a case control study

BACKGROUND: Diabetes mellitus type II afflicts at least 2 million people in Iran. Neuropathy is one of the most common complications of diabetes and lowers the patient's quality of life. Since neuropathy often leads to ulceration and amputation, we have tried to elucidate the factors that can a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Booya, Fargol, Bandarian, Fatemeh, Larijani, Bagher, Pajouhi, Mohammad, Nooraei, Mahdi, Lotfi, Jamshid
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1343576/ https://www.ncbi.nlm.nih.gov/pubmed/16336693 http://dx.doi.org/10.1186/1471-2377-5-24

Ejemplares similares

Vitamin D deficiency and causative factors in the population of Tehran
por: Hashemipour, Sima, et al.
Publicado: (2004)

Endocrinology and Metabolism Research Institute from inception to maturity: an overview of 25-year activity
por: Bandarian, Fatemeh, et al.
Publicado: (2020)

The importance of hypoglycemia in diabetic patients
por: Shafiee, Gita, et al.
Publicado: (2012)

Potentially preventable incidence of diabetes due to risk factor modification
por: Motamedi, Seyed Mohammad Kalantar, et al.
Publicado: (2012)

Changes in clinic visits and diabetes and metabolic control in patients with type 2 diabetes during COVID-19 pandemic: A real world evidence
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

Ramadan fasting and type 1 diabetes: a scoping review protocol
por: Tootee, Ali, et al.
Publicado: (2023)

Physical Activity Behavior During the COVID-19 Outbreak in Individuals with Type 2 Diabetes: Role of Social Support and Other Covariates
por: Peimani, Maryam, et al.
Publicado: (2022)

Scientometric Analysis of Global Scientific Publications on COVID-19 and Diabetes with an Emphasis on Middle Eastern Countries
por: Atlasi, Rasha, et al.
Publicado: (2022)

Who are diabetic foot patients? A descriptive study on 873 patients
por: Madanchi, Nima, et al.
Publicado: (2013)

Iran Diabetes Research Roadmap (IDRR): the study protocol
por: Shafiee, Gita, et al.
Publicado: (2016)

Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy
por: Fateh, Hamid R., et al.
Publicado: (2016)

Insulinoma in Iran: a 20-year review
por: Larijani, Bagher, et al.
Publicado: (2005)

Independent risk factors for amputation in diabetic foot
por: Shojaiefard, Abolfazl, et al.
Publicado: (2008)

National and sub-national burden and trend of type 1 diabetes in 31 provinces of Iran, 1990–2019
por: Bandarian, Fatemeh, et al.
Publicado: (2023)

Dual-energy X-ray absorptiometry diagnostic discordance between Z-scores and T-scores in a young Iranian population
por: Heidari, Behnam, et al.
Publicado: (2014)

The Prevalence of Diabetic Peripheral Neuropathy and Related Factors
por: Tabatabaei-Malazy, O, et al.
Publicado: (2011)

Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross – sectional population based study
por: Fakhrzadeh, Hossein, et al.
Publicado: (2006)

Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial
por: Heshmat, Ramin, et al.
Publicado: (2012)

Normative data of bone Mineral Density in healthy population of Tehran, Iran: A Cross sectional study
por: Larijani, Bagher, et al.
Publicado: (2005)

Policy Implications for Diabetes Prevention and Control: An Experience from Iran
por: Peykari, Niloofar, et al.
Publicado: (2022)

Therapeutic Potential of Polyphenols in the Management of Diabetic Neuropathy
por: Kabir, Md. Tanvir, et al.
Publicado: (2021)

Diabetes in Iran: Prospective Analysis from First Nationwide Diabetes Report of National Program for Prevention and Control of Diabetes (NPPCD-2016)
por: Esteghamati, Alireza, et al.
Publicado: (2017)

Journal of diabetes and metabolic disorders: launch editorial
por: Larijani, Bagher
Publicado: (2012)

Cardiac Autonomic Neuropathy Measured by Heart Rate Variability and Markers of Subclinical Atherosclerosis in Early Type 2 Diabetes
por: Fakhrzadeh, Hossein, et al.
Publicado: (2012)

Investigation The Role of Gender on The HLA-DRB1 and -DQB1 Association with Type 1 Diabetes Mellitus in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2013)

Iran diabetes research roadmap (IDRR) study: a preliminary study on diabetes research in the world and Iran
por: Nasli-Esfahani, Ensieh, et al.
Publicado: (2017)

Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis
por: Mansour, Asieh, et al.
Publicado: (2018)

Data on possible in vitro anti-diabetic effects of verticinone on β-TC6 pancreatic and C2C12 skeletal muscle cells
por: Boojar, Fargol Mashhadi Akbar, et al.
Publicado: (2019)

Treatment of hyperfunctioning thyroid nodules by percutaneous ethanol injection
por: Larijani, Bagher, et al.
Publicado: (2002)

Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy
por: Maghbooli, Zhila, et al.
Publicado: (2014)

Circulating Tumor BRAF Mutation and Personalized Thyroid Cancer Treatment
por: Khatami, Fatemeh, et al.
Publicado: (2017)

Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary healthcare in Qatar
por: Ponirakis, Georgios, et al.
Publicado: (2020)

Effects of Semelil (ANGIPARS™) on diabetic peripheral neuropathy: A randomized, double-blind Placebo-controlled clinical trial
por: Bakhshayeshi, S., et al.
Publicado: (2011)

Cut-off points of waist circumference and body mass index for detecting diabetes, hypercholesterolemia and hypertension according to National Non-Communicable Disease Risk Factors Surveillance in Iran
por: Shabnam, Abbaszadeh-Ahranjani, et al.
Publicado: (2012)

Association of Major Dietary Patterns with Cardio-metabolic Risk Factors in Type 2 Diabetic Patients
por: SHADMAN, Zhaleh, et al.
Publicado: (2016)

Polymorphisms of Antioxidant Genes as a Target for Diabetes Management
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2017)

Beneficial Effects of Anti-Oxidative Herbal Medicines in Diabetic Patients Infected with COVID-19: A Hypothesis
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2020)

Metabolomics profile and 10-year atherosclerotic cardiovascular disease (ASCVD) risk score
por: Dehghanbanadaki, Hojat, et al.
Publicado: (2023)

Identifying Common Genetic Risk Factors of Diabetic Neuropathies
por: Witzel, Ini-Isabée, et al.
Publicado: (2015)

Diabetic Peripheral Neuropathy as a Risk Factor for Sarcopenia
por: Oh, Tae Jung, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nag5q7o6reu2ku3mrl0rdu9kkh